Tsyganov, M. M., Rodionov, E. O., Ibragimova, M. K., Miller, S. V., Cheremisina, O. V., Frolova, I. G., . . . Litvyakov, N. V. Personalized prescription of chemotherapy based on assessment of mRNA expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 genes in tumors compared to standard chemotherapy in the treatment of non-small-cell lung cancer. Journal of personalized medicine, 2022, .
Chicago-стиль цитированияTsyganov, Matvey M., Evgeniy O. Rodionov, Marina K. Ibragimova, Sergey V. Miller, Olga V. Cheremisina, Irina G. Frolova, Sergey A. Tuzikov, and Nicolay V. Litvyakov. "Personalized Prescription of Chemotherapy Based on Assessment of MRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-small-cell Lung Cancer." Journal of Personalized Medicine 2022 ().
MLA-цитированиеTsyganov, Matvey M., et al. "Personalized Prescription of Chemotherapy Based on Assessment of MRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-small-cell Lung Cancer." Journal of Personalized Medicine, 2022, .
